View Transcript
Episode Description
Dr. Greg Cooper talks with Dr. Eric Reiman about emerging antibody therapies for preclinical Alzheimer disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care.
Read the related article in The Lancet Neurology.
Disclosures can be found at Neurology.org.